Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Clermont

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Investigative Ophthalmology & Visual Science|October 29, 2000
Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic ratsF Mori, G L King, A C Clermont, et al.
American Journal of Ophthalmology|November 5, 1997
Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathyA C Clermont, L P Aiello, F Mori, et al.
Investigative Ophthalmology & Visual Science|March 1, 1994
Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumpsA C Clermont, M Brittis, T Shiba, et al.
Investigative Ophthalmology & Visual Science|September 1, 1996
Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxiaC Takagi, G L King, H Takagi, et al.
Current Eye Research|September 1, 1995
Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an alpha-glucosidase inhibitorC Takagi, G L King, A C Clermont, et al.
Investigative Ophthalmology & Visual Science|January 7, 1998
Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic ratsS E Bursell, C Takagi, A C Clermont, et al.
Hypertension (Dallas, Tex. : 1979)|January 7, 2009
Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeabilityJoanna A Phipps, Allen C Clermont, Sukanto Sinha, et al.
Investigative Ophthalmology & Visual Science|April 1, 1996
Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathyS E Bursell, A C Clermont, B T Kinsley, et al.
Diabetologia|November 18, 2003
Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic ratsN Horio, A C Clermont, A Abiko, et al.
Diabetes|May 17, 2015
Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular EdemaTakeshi Kita, Allen C Clermont, Nivetha Murugesan, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Investigative Ophthalmology & Visual Science|October 29, 2000
Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic ratsF Mori, G L King, A C Clermont, et al.
American Journal of Ophthalmology|November 5, 1997
Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathyA C Clermont, L P Aiello, F Mori, et al.
Investigative Ophthalmology & Visual Science|March 1, 1994
Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumpsA C Clermont, M Brittis, T Shiba, et al.
Investigative Ophthalmology & Visual Science|September 1, 1996
Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxiaC Takagi, G L King, H Takagi, et al.
Current Eye Research|September 1, 1995
Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an alpha-glucosidase inhibitorC Takagi, G L King, A C Clermont, et al.
Investigative Ophthalmology & Visual Science|January 7, 1998
Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic ratsS E Bursell, C Takagi, A C Clermont, et al.
Hypertension (Dallas, Tex. : 1979)|January 7, 2009
Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeabilityJoanna A Phipps, Allen C Clermont, Sukanto Sinha, et al.
Investigative Ophthalmology & Visual Science|April 1, 1996
Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathyS E Bursell, A C Clermont, B T Kinsley, et al.
Diabetologia|November 18, 2003
Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic ratsN Horio, A C Clermont, A Abiko, et al.
Diabetes|May 17, 2015
Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular EdemaTakeshi Kita, Allen C Clermont, Nivetha Murugesan, et al.
Pageof 7